Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - CytoDyn Inc. | dex211.htm |
| EX-31.2 - EXHIBIT 31.2 - CytoDyn Inc. | dex312.htm |
| EX-10.9 - EXHIBIT 10.9 - CytoDyn Inc. | dex109.htm |
| EX-10.8 - EXHIBIT 10.8 - CytoDyn Inc. | dex108.htm |
| EX-32.2 - EXHIBIT 32.2 - CytoDyn Inc. | dex322.htm |
| EX-10.7 - EXHIBIT 10.7 - CytoDyn Inc. | dex107.htm |
| EX-31.1 - EXHIBIT 31.1 - CytoDyn Inc. | dex311.htm |
| EX-10.10 - EXHIBIT 10.10 - CytoDyn Inc. | dex1010.htm |
| EX-10.11 - EXHIBIT 10.11 - CytoDyn Inc. | dex1011.htm |
| 10-K/A - FORM 10K/A - CytoDyn Inc. | d10ka.htm |
Exhibit 32.1
Certification of the Chief Executive Officer
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CytoDyn Inc. (the “Company”) on Form 10-K/A for the fiscal year ended May 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-K/A”), I, Kenneth J. Van Ness, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Form 10-K/A fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The information contained in the Form 10-K/A fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 4, 2011
| By: | /s/ Kenneth J. Van Ness | |
| Name: | Kenneth J. Van Ness | |
| Title: | President and Chief Executive Officer |